Evidence map›Paper›PMID 36409895›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

Modulation of cGAS-STING signaling by PPARα in a mouse model of ischemia-induced retinopathy.

Xiang Ma, Wenjing Wu, Wentao Liang, Yusuke Takahashi, Jiyang Cai, Jian-Xing Ma

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
5.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. [Melatonin alleviates cardiomyocyte necroptosis in diabetic mice by inhibiting the STING signaling pathway].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2026
    Article
  3. Article
  4. Microglial polarization in retinal neovascularization: Friend or foe?Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2026
    Review
  5. Article
  6. Fenofibrate in ophthalmology: therapeutic efficacy and mechanisms.Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2026
    Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Xiang MaDepartment of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104.
Wenjing WuDepartment of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104.
Wentao LiangDepartment of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104.ORCID 0000-0002-0609-6280
Yusuke TakahashiDepartment of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104.
Jiyang CaiDepartment of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104.ORCID 0000-0003-4755-5452
Jian-Xing MaDepartment of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104.
Wake Forest University · USUniversity of Oklahoma Health Sciences Center · US

Funding

P30-CENTER CORE GRANT FOR VISION RESEARCHP30EY021725 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Michelle C Callegan, MICHAEL H ELLIOTT · 2011 to 2026
$10.5M
A new pathogenic mechanism for diabetic retinopathyR01EY019309 · NEI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Jian-Xing Jay Ma · 2009 to 2026
$6.1M
STUDIES OF RPE65R01EY012231 · NEI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI MA, JIAN-XING, MOISEYEV, GENNADIY · 1998 to 2021
$5.7M
Pilot Project ProgramP30GM122744 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI LE, YUN ZHENG · 2017 to 2021
$5.5M
Sustained release of fenofibrate for the treatment of diabetic retinopathyR01EY033477 · NEI · VIRGINIA COMMONWEALTH UNIVERSITY · PI Jian-Xing Jay Ma, QINGGUO XU · 2022 to 2026
$2.7M
A Novel Pathogenic Pathway for Diabetic KeratopathyR01EY028949 · NEI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Dimitrios Karamichos, Jian-Xing Jay Ma · 2018 to 2026
$2.2M
Small Molecule PPAR-alpha Agonism as a Novel Approach to Treat Eye Vascular DiseasesR01EY030472 · NEI · UNIVERSITY OF OKLAHOMA · PI DUERFELDT, ADAM SCOTT · 2020 to 2024
$2.1M
cGAS-STING signaling in diabetic retinopathyR01EY033330 · NEI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Jian-Xing Jay Ma, Yusuke Takahashi · 2022 to 2026
$1.9M
Dysregulation of Wnt signaling in subretinal fibrosis in AMDR01EY032931 · NEI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI TAKAHASHI, YUSUKE · 2021 to 2025
$1.9M
Studies of retinyl ester hydrolase in the visual cycleR01EY032930 · NEI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI MA, JIAN-XING JAY, MOISEYEV, GENNADIY · 2021 to 2025
$1.9M
Choroidal Gamma Delta T Cells as Novel Regulators of RPE DegenerationR01EY028773 · NEI · UNIVERSITY OF TEXAS MED BR GALVESTON · PI CAI, JIYANG · 2018 to 2021
$1.8M
NEI NIH HHS P30 EY021725NEI NIH HHS R01 EY012231NEI NIH HHS R01 EY019309NEI NIH HHS R01 EY028773NEI NIH HHS R01 EY028949NEI NIH HHS R01 EY030472NEI NIH HHS R01 EY032930NEI NIH HHS R01 EY032931NEI NIH HHS R01 EY033330NEI NIH HHS R01 EY033477NIGMS NIH HHS P30 GM122744
6 · The paper itself

Abstract

In ischemic retinopathy, overactivated retinal myeloid cells are a crucial driving force of pathological angiogenesis and inflammation. The cyclic GMP-AMP synthase (cGAS) and stimulator of interferon genes (STING) signaling are key regulators of inflammation. This study aims to investigate the association of cGAS-STING signaling with ischemic retinopathy and the regulation of its activation. We found that protein levels of cGAS and STING were markedly up-regulated in retinal myeloid cells isolated from mice with oxygen-induced retinopathy (OIR). Knockout of

Indexed as

PPAR alphaRetinal DiseasesAnimalsDisease Models, AnimalDNA, MitochondrialInflammationIschemiaMembrane ProteinsMiceMice, KnockoutNeovascularization, PathologicNucleotidyltransferasesSTING ProteinDNA, MitochondrialMembrane ProteinsNucleotidyltransferasesPPAR alphaSting1 protein, mouseSTING ProteincGAS-STING signalingischemia-induced retinopathymyeloid cellsneovascularizationPPARα

Identifiers

PMID36409895
PMCPMC9860285
OpenAlexW4309658084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.